In vitro assessment of a novel polyrotaxane-based drug delivery system integrated with a cell-penetrating peptide

Journal of Controlled Release

Volumn 124, Issue 1-2, 2007, Pages 43-50

  Moon, Cheol ^a,b   Kwon, Young Min ^b   Lee, Won Kyu ^c   Park, Yoon Jeong ^d   Yang, Victor C ^a,b  

^a TIANJIN UNIVERSITY   (China)

^b UNIVERSITY OF MICHIGAN   (United States)

^c Korea Food and Drug Administration   (South Korea)

^d School of Dentistry   (South Korea)

Author keywords

Daunorubicin; Doxorubicin; Heparin inhibition; Low molecular weight protamine; Polyrotaxane

Indexed keywords

DAUNORUBICIN; DOXORUBICIN; HEPARIN INHIBITION; LOW MOLECULAR WEIGHT PROTAMINE; POLYROTAXANE;

CYTOTOXICITY; DRUG PRODUCTS; ONCOLOGY; PEPTIDES; SELF ASSEMBLY; TISSUE;

DRUG DELIVERY;

ALPHA CYCLODEXTRIN; DAUNORUBICIN; DOXORUBICIN; DRUG CARRIER; HEPARIN; PEPTIDE DERIVATIVE; POLYROTAXANE; PROTAMINE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG CONJUGATION; DRUG PENETRATION; DRUG SYNTHESIS; DRUG UPTAKE; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; CYCLODEXTRINS; DAUNORUBICIN; DOXORUBICIN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; POLOXAMER; PROTAMINES; ROTAXANES; SOLUBILITY;

EID: 36148945638     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2007.08.029     Document Type: Article

References (30)

1. Jain R.K. Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function. J. Control. Release 74 1-3 (2001) 7-25
2. Maeda H., Wu J., Sawa T., Matsumura Y., and Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Control. Release 65 1-2 (2000) 271-284
3. Dvorak H.F., Nagy J.A., Dvorak J.T., and Dvorak A.M. Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. Am. J. Pathol. 133 1 (1988) 95-109
4. Matsumura Y., and Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 46 12 Pt 1 (1986) 6387-6392
5. Maeda H., Sawa T., and Konno T. Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. J. Control. Release 74 1-3 (2001) 47-61
6. Greco F., Vicent M.J., Gee S., Jones A.T., Gee J., Nicholson R.I., and Duncan R. Investigating the mechanism of enhanced cytotoxicity of HPMA copolymer-Dox-AGM in breast cancer cells. J. Control. Release 117 1 (2007) 28-39
7. Greenwald R.B. PEG drugs: an overview. J. Control. Release 74 1-3 (2001) 159-171
8. Singer J.W. Paclitaxel poliglumex (XYOTAX, CT-2103): a macromolecular taxane. J. Control. Release 109 1-3 (2005) 120-126
9. Eguchi M., Ooya T., and Yui N. Controlling the mechanism of trypsin inhibition by the numbers of alpha-cyclodextrins and carboxyl groups in carboxyethylester-polyrotaxanes. J. Control. Release 96 2 (2004) 301-307
10. Dietz G.P., and Bahr M. Delivery of bioactive molecules into the cell: the Trojan horse approach. Mol. Cell. Neurosci. 27 2 (2004) 85-131
11. Schwarze S.R., Ho A., Vocero-Akbani A., and Dowdy S.F. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285 5433 (1999) 1569-1572
12. Chauhan A., Tikoo A., Kapur A.K., and Singh M. The taming of the cell penetrating domain of the HIV Tat: myths and realities. J. Control. Release 117 2 (2007) 148-162
13. Vives E., Brodin P., and Lebleu B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272 25 (1997) 16010-16017
14. Elliott G., and O'Hare P. Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell 88 2 (1997) 223-233
15. Derossi D., Joliot A.H., Chassaing G., and Prochiantz A. The third helix of the Antennapedia homeodomain translocates through biological membranes. J. Biol. Chem. 269 14 (1994) 10444-10450
16. Suzuki T., Futaki S., Niwa M., Tanaka S., Ueda K., and Sugiura Y. Possible existence of common internalization mechanisms among arginine-rich peptides. J. Biol. Chem. 277 4 (2002) 2437-2443
17. Park Y.J., Chang L.C., Liang J.F., Moon C., Chung C.P., and Yang V.C. Nontoxic membrane translocation peptide from protamine, low molecular weight protamine (LMWP), for enhanced intracellular protein delivery: in vitro and in vivo study. FASEB J. 19 11 (2005) 1555-1557
18. Vives E. Present and future of cell-penetrating peptide mediated delivery systems: "is the Trojan horse too wild to go only to Troy". J. Control. Release 109 1-3 (2005) 77-85
19. Han G., Tamaki M., and Hruby V.J. Fast, efficient and selective deprotection of the tert-butoxycarbonyl (Boc) group using HCl/dioxane (4 m). J. Pept. Res. 58 4 (2001) 338-341
20. F. Arcamone, G. Franceschi, S. Penco, Process for the preparation of adriamycin and adriamycinone and adriamycin derivatives, US Patent 3803124, April 9, 1974.
21. Tanaka H., Kominato K., Yamamoto R., Yoshioka T., Nishida H., Tone H., and Okamoto R. Synthesis of doxorubicin-cyclodextrin conjugates. J. Antibiotics 47 9 (1994) 1025-1029
22. Hruby M., Konak C., and Ulbrich K. Polymeric micellar pH-sensitive drug delivery system for doxorubicin. J. Control. Release 103 1 (2005) 137-148
23. Snyder S.L., and Sobocinski P.Z. An improved 2,4,6-trinitrobenzenesulfonic acid method for the determination of amines. Anal. Biochem. 64 1 (1975) 284-288
24. Kang H.C., Kim S., Lee M., and Bae Y.H. Polymeric gene carrier for insulin secreting cells: poly(l-lysine)-g-sulfonylurea for receptor mediated transfection. J. Control. Release 105 1-2 (2005) 164-176
25. Ramanathan S., Qiu B., Pooyan S., Zhang G., Stein S., Leibowitz M.J., and Sinko P.J. Targeted PEG-based bioconjugates enhance the cellular uptake and transport of a HIV-1 TAT nonapeptide. J. Control. Release 77 3 (2001) 199-212
26. Harada A., and Kamachi M. Complex formation between poly(ethylene glycol) and -cyclodextrin. Macromolecules 23 10 (1990) 2821-2823
27. Ooya T., and Yui N. Multivalent interactions between biotin-polyrotaxane conjugates and streptavidin as a model of new targeting for transporters. J. Control. Release 80 1-3 (2002) 219-228
28. Sugahara S., Kajiki M., Kuriyama H., and Kobayashi T.R. Paclitaxel delivery systems: the use of amino acid linkers in the conjugation of paclitaxel with carboxymethyldextran to create prodrugs. Biol. Pharm. Bull. 25 5 (2002) 632-641
29. Schoenmakers R.G., van de Wetering P., Elbert D.L., and Hubbell J.A. The effect of the linker on the hydrolysis rate of drug-linked ester bonds. J. Control. Release 95 2 (2004) 291-300
30. Hoes C.J.T., Potman W., van Heeswijk W.A.R., Mud J., de Grooth B.G., Greve J., and Feijen J. Optimization of macromolecular prodrugs of the antitumor antibiotic Adriamycin. J. Control. Release 2 (1985) 205-213